The effect of combined preinduction thoracic epidural anaesthesia and glucocorticoid administration in perioperative interleukin-10 levels and hyperglycemia. A randomized controlled trial

Journal of Cardiovascular Surgery

Volumn 49, Issue 1, 2008, Pages 87-93

  Kiliçkan, Levent ^a,b   Yumuk, Z ^c   Bayindir, O ^a  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b Kocaeli University School of Medicine ^*  (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

Author keywords

Anaesthesia, general; Anesthesia, epidural; Blood glucose; Cardiac surgical procedures; Interleukin 10

Indexed keywords

BUPIVACAINE; CORTICOSTEROID; FENTANYL; GLUCOCORTICOID; GLUCOSE; HEPARIN; INTERLEUKIN 10; METHYLPREDNISOLONE; MIDAZOLAM; PETHIDINE; PROPOFOL; STEROID; VECURONIUM;

ADULT; AGED; ANESTHESIA INDUCTION; ARTERY CATHETER; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; EPIDURAL CATHETER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; THORAX EPIDURAL ANESTHESIA;

AGED; ANESTHESIA, EPIDURAL; ANESTHETICS, LOCAL; BLOOD GLUCOSE; BUPIVACAINE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREANESTHETIC MEDICATION; PROSPECTIVE STUDIES; THORACIC VERTEBRAE; TIME FACTORS; TREATMENT OUTCOME;

EID: 40449103810     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gu YJ, Mariam MA, van Oeveren W, Grandjean JG, Boonstra PW. Reduction of the inflammatory response in patients undergoing minimally invasive coronary attery bypass grafting. Arm Thorac Surg 1998;65:420-4.
2. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 1996;61:1714-20.
3. Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 2003;76:117-23.
4. Moore CM, Cross MH, Desborough JP, Burrin JM, Mac Donald IA, Hall GM, Hormonal effects of thoracic extradural analgesia for cardiac surgery. Br J Anaesth 1995;75:387-93
5. Platzer C, Döcke WD, Volk HD, Prösch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its prometer/enhancer activity in monocytic cells. J Neuroimmunol 2000;105:31-8.
6. Volk T, Schmutzler M, Engelhardt L, Docke WD, Volk HD, Konertz W. Influence of ammosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 2001;29:2137-42.
7. Hodge S, Hodge G, Flower R, Han P. Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood. Scand J Immunol 1999;49:548-53.
8. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998;4:808-13.
9. Volk T, Döpfmer UR, Schmutzler M, Rimpau S, Schnitzler H, Konertz W et al. Stress induced IL-10 does not seem to be essential for early monocyte deactivation following cardiac surgery. Cytokine 2003;24:237-43
10. Muhlestein JB, Anderson JI, Horne BD. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 2003; 146:351-8.
11. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
12. Mesotten D, Delhanty JD, Vanderhoydonc F. Intensive insulin therapy in the critically ill patients. J Clin Endocrin Metab 2003,87:5516-23.
13. Van den Berghe G, Wouters P, Weekers F. Intensive insulin therapy in the critically ill patients. New Engl J Med 2001;345:1359-67.
14. Sablotzki A, Dehne MG, Mann V. Plasma levels of selections and interleukins in cardiovascular surgery using cardiopulmonary bypass. Thorac Cardiovasc Surg 1999;47:26-31.
15. Kawamura T, Inada K, Nara N, Wakusawa R, Endo S. Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999;27:545-8.
16. Tabardel Y, Duchateau J, Schmartz D. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996;119:76-80.
17. Ganapathy S. Stress and inflammatory response after beating heart surgery versus conventional bypass surgery: the role of thoracic epidural anesthesia. Heart Surg Forum 2001;4:323-7.
18. Mc Knight CK, Elliott MJ, Pearson DT. The effects of four different crystalloid bypass pump-priming fluids upon the metabolic response to cardiac operation. J Thorac Cardiovasc Surg 1985;90:97-111.
19. Werb MR, Zinman B, Teasdale SJ. Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab 1989;69:1010-8.
20. Kuntschen FR, Galletti PM, Hahn C. Glucose-insulin interactions during cardiopulmonary bypass: hypothermia versus normothermia. J Thorac Cardiovasc Surg 1986;91:451-9.
21. Braden H, Cheema-Dhadli S, Mazer CD. Hyperglycemia during normothermic cardiopulmonary bypass: the role of the kidney. Ann Thorac Surg 1998;65:1588-93.
22. Metz S, Keats AS. Benefits of a glucose-containing priming solution for cardiopulmonary bypass. Anaesth Analg 1991;72:428-34.
23. Stenseth R, Bjella L, Berg EM, Christensen O, Levang OW, Gisvold SE. Thoracic epidural analgesia in aortocoronary bypass surgery. II. Effects on the endocrine metabolic response. Acta Anaesth Scand 1994;38:834-9.
24. Richardson J, Sabanathan S, Jones J, Shah RD, Cheema S, Mearns AJ. A prospective, randomized comparison of preoperative and continuous balanced epidural or paravertabral bupivacaine on post-thoractomy pain, pulmonary function and stress responses. Br J Anaesth 1999;83:387-92.
25. Stephens JW, Krause AH, Peterson CA. The effect of glucose primng solutions in diabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1988;45:544-7.
26. Higgins TL, Estafanous FG, Loop CD. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann Thorac Surg 1997;64:1050-8.
27. Rady MY, Ryan T, Starr NJ. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 1998;26:225-35.
28. Lacoumenta S, Yeo TH, Paterson JL. Hormonal and metabolic responses to cardiac surgery with sufentanil-oxygen anaesthesia. Acta Anaesthesiol Scand 1987;31:258-63.
29. Gott JP, Cooper WA, Schmidt FFJ. Modifying risk for extracorporeal circulation. Trial of four anti-inflammatory strategies. Ann Thorac Surg 1998;66:747-53.
30. Teoh KH, Bradley CA, Gauldie J. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1995;92:11347-53.
31. Chaney MA, Nikolov MP, Blakeman B. Pulmonary effects of methyl-prednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998;87:27-33.
32. Chaney MA, Nikolov MP, Blakeman B. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation. Ann Thorac Surg 1999;67:1006-11.
33. Mayumi H, Zhang QW, Nakashima A. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 1997;63:129-37.
34. Weissman C. The metabolic response to stress. An overview and update. Anesthesiology 1990;73:308-27.
35. Stanley TH, Berman L, Green O. Plasma catecholamme and cortisol responses to fentanyl-oxygen anesthesia for coronary artery operations. Anesthesiology 1980;53:250-3.
36. Yerkovich ST, Rigby PJ, Fournier PA, Olynyk JK, Yeoh GC. Kupffer cell cytokines interleukin-1 beta and interleukin-10 combine to inhibit phosphoenolpyruvate carboxykinase and gluconeogenesis in cultured hepatocytes. Int J Biochem Cell Biol 2004;36:1462-72.
37. de Galan BE, Netea MG, Smits P, van der Meer JW. Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-alpha, but does not affect IL-1beta, IL-6, or IL-10. Cytokine 2003;22:71-6.